Clinical evidence dossier
Instructional WhatsApp group for diabetes self-care
Diabetes self-management behaviors
Evidence signal
Authoritative evidence signal
strong
This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.
Evidence snapshot
- Authoritative support records
- 4
- Supporting studies available for review
- 4
- Randomized trials
- 2
- Reported effects
- 2
Clinical conclusion
Instructional WhatsApp group for diabetes self-care shows a strong positive evidence signal for improving Diabetes self-management behaviors across the studied comparisons.
Observed effects
Evidence composition
- Non-randomized studies
- 0
- Other designs
- 0
- Unresolved designs
- 2
- Magnitude-eligible effects
- 0
Consistency
Authoritative consistency classification
consistent
- Positive
- 4
- No effect
- 0
- Mixed
- 0
- Negative
- 0
Population and applicability
Structured population data were available for 4 of 4 supporting studies. Diabetes type was heterogeneous: 1 studies with type 1 diabetes, 1 studies with type 2 diabetes. Age groups were heterogeneous: 1 studies with adult participants, 1 studies with youth participants.
This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.
View reported population descriptions
These descriptions are reported across the supporting studies; they are not a single synthesized population.
- Adults diagnosed with Type 2 diabetes.
- Patients seeking to improve their self-management skills.
- Individuals with diabetes seeking to improve self-management.
- Patients experiencing anxiety and depression related to diabetes.
- Palestinian children diagnosed with Type 1 Diabetes Mellitus.
- Children aged 6-18 years managing diabetes.
- Women diagnosed with gestational diabetes mellitus.
- Pregnant women experiencing high levels of stress.
Limitations
- 2 relevant studies have unresolved authoritative design evidence and do not contribute to design-specific or RoB-specific claims.
- 2 supporting studies do not have a displayable topic-matched quantitative effect.
- 2 supporting studies have high, serious, critical, unclear, or unavailable risk-of-bias information.
- 2 of 4 studies with duration data have follow-up of 12 weeks or less.
Supporting evidence
Inspect the authoritative studies and omitted support records for this dossier.